Terms: = Lymphoma AND CAD-ALK AND Treatment
2 results:
1. Tracking a cad-alk gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.
Siravegna G; Sartore-Bianchi A; Mussolin B; Cassingena A; Amatu A; Novara L; Buscarino M; Corti G; Crisafulli G; Bartolini A; Tosi F; Erlander M; Di Nicolantonio F; Siena S; Bardelli A
Ann Oncol; 2017 Jun; 28(6):1302-1308. PubMed ID: 28368455
[TBL] [Abstract] [Full Text] [Related]
2. Novel cad-alk gene rearrangement is drugable by entrectinib in colorectal cancer.
Amatu A; Somaschini A; Cerea G; Bosotti R; Valtorta E; Buonandi P; Marrapese G; Veronese S; Luo D; Hornby Z; Multani P; Murphy D; Shoemaker R; Lauricella C; Giannetta L; Maiolani M; Vanzulli A; Ardini E; Galvani A; Isacchi A; Sartore-Bianchi A; Siena S
Br J Cancer; 2015 Dec; 113(12):1730-4. PubMed ID: 26633560
[TBL] [Abstract] [Full Text] [Related]
